China FDA Requests Changes To Meropenem Use Manual
This article was originally published in PharmAsia News
Executive Summary
In order to control clinical risks from meropenem, an antibiotic for the treatment of pneumonia, urinary tract infections and gynecological infections, the China FDA has requested changes to its use manual.